Squarepoint Ops »

Parabilis Medicines shares owned by Squarepoint Ops

Quarter-by-quarter ownership of Parabilis Medicines shares owned by Squarepoint Ops from 13F filings

Historical chart of Squarepoint Ops investment in Parabilis Medicines

Tip: Access up to 7 years of quarterly data

All positions including Parabilis Medicines held by Squarepoint Ops consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Parabilis Medicines by Squarepoint Ops

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.3M 49k 27.37

More positions owned by Squarepoint Ops

Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Advanced Micro Devices (AMD)
Ishares Tr Russell 2000 Etf (IWM)
Micron Technology (MU)
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Apple (AAPL)
Applied Materials (AMAT)
Tesla Motors (TSLA)
Intel Corporation (INTC)
Ishares Tr 20 Yr Tr Bd Etf (TLT)

View all positions for Squarepoint Ops

Top funds holding Parabilis Medicines

RA Capital Management
FMR
Arch Venture Corp
venBio Partners
Alphabet
Nextech Invest
Cormorant Asset Management
Regeneron Pharmaceuticals
Siren
Farallon Capital Management
Jupiter Topco
Frazier Life Sciences Management
Deerfield Management Company
General Catalyst Group Management
General Atlantic

View all funds holding Parabilis Medicines